Table 2. Univariable analysis of... | American Society of Hematology

Table 2.

Univariable analysis of outcomes in patients treated with auto-HCT or CAR-T while in a PR

	Auto-HCT (N = 266)		CAR-T (N = 145)
Outcomes	N eval	Prob (95% CI)	N eval	Prob (95% CI)	P value
Nonrelapse mortality	256		138		.2*
100 d		4 (2-7)		2 (0-5)	.3†
1 y		7 (4-11)		3 (1-6)	.05†
2 y		9 (5-13)		6 (1-16)	.6†
Progression/relapse	256		138		.01*
1 y		34% (28-40)		45% (37-54)	.03†
2 y		40% (33-46)		52% (41-63)	.05†
Progression-free survival	256		138		.1*
1 y		59% (53-65)		52% (43-61)	.2†
2 y		52% (46-58)		42% (30-53)	.1†
Overall survival	266		145		.01*
1 y		76% (70-81)		67% (59-75)	.1†
2 y		69% (63-74)		47% (33-60)	.004†

	Auto-HCT (N = 266)		CAR-T (N = 145)
Outcomes	N eval	Prob (95% CI)	N eval	Prob (95% CI)	P value
Nonrelapse mortality	256		138		.2*
100 d		4 (2-7)		2 (0-5)	.3†
1 y		7 (4-11)		3 (1-6)	.05†
2 y		9 (5-13)		6 (1-16)	.6†
Progression/relapse	256		138		.01*
1 y		34% (28-40)		45% (37-54)	.03†
2 y		40% (33-46)		52% (41-63)	.05†
Progression-free survival	256		138		.1*
1 y		59% (53-65)		52% (43-61)	.2†
2 y		52% (46-58)		42% (30-53)	.1†
Overall survival	266		145		.01*
1 y		76% (70-81)		67% (59-75)	.1†
2 y		69% (63-74)		47% (33-60)	.004†

N eval, number evaluated; Prob, probability.

Overall P values from the log-rank test (PFS and OS) and Gray’s test (NRM and progression/relapse).

P values from the Wald test given time.